S&P 500 Healthcare Sector SEC Filings — February 18, 2026

19-02-2026

Praxis Precision Medicines, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001689548-26-000028), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet metrics, guidance, or quantitative financial data are disclosed in the provided filing description. This is an informational earnings-related disclosure with no directional performance indicators available.

19-02-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001062993-26-001059, Size: 514 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details provided on the nature of the other events or the content of any exhibits. No quantitative metrics, financial impacts, or directional changes are disclosed.

19-02-2026

CVB Financial Corp filed an 8-K on 2026-02-19 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including affected positions, individuals involved, reasons for change, or any quantitative terms were provided in the filing summary. Sector is not specified.

19-02-2026

Occidental Petroleum Corp filed an 8-K on February 19, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosure content, financial metrics, transactions, or events are provided in the filing summary. The filing size is 266 KB with Accession Number 0000950157-26-000166.

19-02-2026

Six Flags Entertainment Corporation filed a Form 8-K on February 19, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This is an informational earnings-related disclosure with no quantitative details available.

19-02-2026

News Corp filed an 8-K on February 19, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other event, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. This is a multi-item voluntary disclosure with no quantitative data or directional implications mentioned.

19-02-2026

Cassava Sciences Inc filed an 8-K on February 19, 2026, disclosing under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the core events, financial impacts, or quantitative metrics are explicitly stated in the provided filing information. This appears to be a multi-item informational filing with no directional financial data disclosed.

19-02-2026

Tectonic Financial, Inc. filed an 8-K on February 19, 2026, under Item 8.01 Other Events. No specific details of the event, financial metrics, or quantitative data are disclosed in the provided filing information. This is a voluntary disclosure with no mentioned positive or negative impacts.

19-02-2026

Core Scientific, Inc. filed a Form 8-K on February 19, 2026, under Items 1.01, 5.02, and 9.01, disclosing entry into a material definitive agreement and matters related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No quantitative financial metrics, transaction values, personnel names, or other specific details are provided in the filing summary.

19-02-2026

BOK Financial Corp filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, individual names, appointment/resignation status, reasons, or timing are disclosed.

19-02-2026

NewtekOne, Inc. filed an 8-K on February 19, 2026, under Item 2.03 disclosing the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 8.01 reports other events. No specific transaction details, dollar values, strategic context, or other quantitative metrics are disclosed.

19-02-2026

Ategrity Specialty Insurance Co Holdings filed a Form 8-K on February 19, 2026, under Item 8.01 Other Events. This is a single-item voluntary disclosure with no specific details on the event, transaction, or financial impacts provided in the filing metadata. No quantitative metrics, comparisons, or scheduled events are disclosed.

19-02-2026

Newmont Corp /DE/ filed an 8-K on February 19, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits provided under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or quantitative metrics are disclosed in the filing summary. This appears to be a standard earnings-related disclosure without detailed financial data provided.

19-02-2026

CIMG Inc. filed an 8-K on February 19, 2026, reporting changes in its certifying accountant under Item 4.01. Item 9.01 discloses financial statements and exhibits. No additional details, financial metrics, reasons for the change, or quantitative data are provided.

19-02-2026

Matthews International Corp filed an 8-K on 2026-02-19 disclosing Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on officer changes, governance amendments, voting outcomes, or any quantitative metrics such as transaction values, share counts, or percentage changes are disclosed. No positive or negative performance metrics were mentioned.

19-02-2026

OneWater Marine Inc. filed a Form 8-K on February 19, 2026, reporting Item 5.07 regarding the submission of matters to a vote of security holders. No specific proposals, vote outcomes, numerical tallies, or other details are disclosed in the provided filing information. This is purely informational with no financial metrics or directional implications mentioned.

19-02-2026

Pulse Biosciences, Inc. filed an 8-K on 2026-02-19 reporting entry into a new material definitive agreement under Item 1.01 and termination of a prior material definitive agreement under Item 1.02, with exhibits provided under Item 9.01. This multi-item filing signals a potential strategic shift involving both a new commitment and the end of an existing one. Specific terms, parties, financial impacts, and strategic details are NOT_DISCLOSED.

19-02-2026

Amgen Inc filed an 8-K on 2026-02-19 under Item 1.01 disclosing entry into a Material Definitive Agreement and Item 9.01 for Financial Statements and Exhibits. No details on the agreement's nature, counterparties, terms, or financial implications are provided. No quantitative metrics, positive or negative changes, or scheduled events are mentioned.

19-02-2026

19-02-2026

Columbus Circle Capital Corp II filed an 8-K on February 19, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on affected positions, individuals involved, reasons for the change, or any quantitative impacts were disclosed. No positive or negative metrics, performance comparisons, or governance implications were provided.

• ·Filing Accession Number: 0001213900-26-018446
• ·File Size: 469 KB
• ·Sector: not specified

19-02-2026

Lifeward Ltd. filed an 8-K on February 19, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. No quantitative details such as transaction value, financial terms, or impacts were disclosed. This is a multi-item mandatory filing with limited specifics provided.

19-02-2026

Fidelity National Financial, Inc. filed a Form 8-K on 2026-02-19 disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing description. This represents a standard mandatory earnings-related disclosure without detailed performance data available.